Brief: Establishment Labs Completes 21 Motiva Mia Patients In IRB Approved Study In Costa Rica
10/12/2020 14:38
Dec 10 (Reuters) - Establishment Labs Holdings Inc ESTA.O :
* ESTABLISHMENT LABS COMPLETES 21 MOTIVA MIA PATIENTS IN IRB
APPROVED STUDY IN COSTA RICA
Source text for Eikon: ID:nGNX5w6lgk
Further company coverage: ESTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Establishment Labs Holdings
See all newsU.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector
Establishment Labs gains on US FDA approval for more Motiva implant sizes
Brief: Establishment Labs Receives FDA Approval For Additional Sizes Of Motiva Implants
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp